HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,081,152 | -6.9% | 368,665 | 0.0% | 9.78% | +18.0% |
| Q2 2023 | $12,973,321 | +7.8% | 368,665 | 0.0% | 8.29% | +1.2% |
| Q1 2023 | $12,036,912 | -40.7% | 368,665 | 0.0% | 8.19% | -41.5% |
| Q4 2022 | $20,313,442 | -10.2% | 368,665 | -27.9% | 14.00% | -3.1% |
| Q3 2022 | $22,631,000 | -27.0% | 510,978 | -19.7% | 14.44% | -32.2% |
| Q2 2022 | $31,017,000 | -17.1% | 635,978 | -17.3% | 21.30% | +20.1% |
| Q1 2022 | $37,398,000 | +14.1% | 768,708 | 0.0% | 17.74% | +82.9% |
| Q4 2021 | $32,778,000 | +11.2% | 768,708 | 0.0% | 9.70% | +2.8% |
| Q3 2021 | $29,465,000 | +35.8% | 768,708 | 0.0% | 9.43% | +39.9% |
| Q2 2021 | $21,701,000 | – | 768,708 | – | 6.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |